339 related articles for article (PubMed ID: 9784315)
1. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.
Dabrow MB; Francesco MR; McBrearty FX; Caradonna S
Gynecol Oncol; 1998 Oct; 71(1):29-37. PubMed ID: 9784315
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.
Henriksen R; Funa K; Wilander E; Bäckström T; Ridderheim M; Oberg K
Cancer Res; 1993 Oct; 53(19):4550-4. PubMed ID: 8402626
[TBL] [Abstract][Full Text] [Related]
3. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells.
Syed V; Ulinski G; Mok SC; Yiu GK; Ho SM
Cancer Res; 2001 Sep; 61(18):6768-76. PubMed ID: 11559549
[TBL] [Abstract][Full Text] [Related]
4. Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo.
Langerak AW; De Laat PA; Van Der Linden-Van Beurden CA; Delahaye M; Van Der Kwast TH; Hoogsteden HC; Benner R; Versnel MA
J Pathol; 1996 Feb; 178(2):151-60. PubMed ID: 8683381
[TBL] [Abstract][Full Text] [Related]
5. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer.
Lindmark G; Sundberg C; Glimelius B; Påhlman L; Rubin K; Gerdin B
Lab Invest; 1993 Dec; 69(6):682-9. PubMed ID: 8264231
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
7. Expression of platelet-derived growth factor-beta receptors on human fibroblasts. Regulation by recombinant platelet-derived growth factor-BB, IL-1, and tumor necrosis factor-alpha.
Tingström A; Reuterdahl C; Lindahl P; Heldin CH; Rubin K
J Immunol; 1992 Jan; 148(2):546-54. PubMed ID: 1309561
[TBL] [Abstract][Full Text] [Related]
8. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
Coltrera MD; Wang J; Porter PL; Gown AM
Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytokines and receptors in normal, immortalized, and malignant ovarian epithelial cell lines.
Bandera CA; Tsui HW; Mok SC; Tsui FW
Anticancer Res; 2003; 23(4):3151-7. PubMed ID: 12926048
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor A and B chains and the alpha and beta receptors in prostatic intraepithelial neoplasia.
Fudge K; Bostwick DG; Stearns ME
Prostate; 1996 Nov; 29(5):282-6. PubMed ID: 8899000
[TBL] [Abstract][Full Text] [Related]
12. Differential chemotactic responses mediated by platelet-derived growth factor alpha- and beta-receptors.
Hayashi N; Takehara K; Soma Y
Arch Biochem Biophys; 1995 Oct; 322(2):423-8. PubMed ID: 7574717
[TBL] [Abstract][Full Text] [Related]
13. Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study.
Schilder RJ; Sill MW; Lee RB; Shaw TJ; Senterman MK; Klein-Szanto AJ; Miner Z; Vanderhyden BC
J Clin Oncol; 2008 Jul; 26(20):3418-25. PubMed ID: 18612157
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor: receptor expression in corneas and effects on corneal cells.
Hoppenreijs VP; Pels E; Vrensen GF; Felten PC; Treffers WF
Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):637-49. PubMed ID: 8449682
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor induces proliferation of hyperplastic human prostatic stromal cells.
Vlahos CJ; Kriauciunas TD; Gleason PE; Jones JA; Eble JN; Salvas D; Falcone JF; Hirsch KS
J Cell Biochem; 1993 Aug; 52(4):404-13. PubMed ID: 7693727
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
[TBL] [Abstract][Full Text] [Related]
17. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
Ho SM; Lau KM; Mok SC; Syed V
Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
[TBL] [Abstract][Full Text] [Related]
18. Localization of platelet-derived growth factor beta receptor expression in the periepithelial stroma of human breast carcinoma.
Bhardwaj B; Klassen J; Cossette N; Sterns E; Tuck A; Deeley R; Sengupta S; Elliott B
Clin Cancer Res; 1996 Apr; 2(4):773-82. PubMed ID: 9816230
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
[TBL] [Abstract][Full Text] [Related]
20. Loss of coordinated androgen regulation in nonmalignant ovarian epithelial cells with BRCA1/2 mutations and ovarian cancer cells.
Evangelou A; Letarte M; Jurisica I; Sultan M; Murphy KJ; Rosen B; Brown TJ
Cancer Res; 2003 May; 63(10):2416-24. PubMed ID: 12750261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
